@WIRED 6 years ago
Medicare patients with advanced cancers will now have access to a more 21st century diagnostic: gene-sequencing tests to match them with the right drugs.
@WIRED 6 years ago
Medicare patients with advanced cancers will now have access to a more 21st century diagnostic: gene-sequencing tests to match them with the right drugs.
@WIRED 8 years ago
Cofactor is an RNA sequencing company that's turning away from drug discovery for big pharma toward consumer diagnostics.